BeStock  
Stocks › Biotechnology › OMER

Omeros OMER

US equityMarket cap rank #3176Biotechnology
$13.21 −$0.80 (-5.71%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $13.19 -0.15%
Open$13.78
Prev close$14.01
Day range$13.07 – $13.88
Volume2.02M
Market cap$983.66M
P/E (TTM)8.5
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$28.53M
Operating profit$74,000.00+100.2% YoY
Net profit$13.23M+152.0% YoY
Diluted EPS$0.15+134.9% YoY
Free cash flow$4.10M+118.7% YoY
Operating cash flow$4.15M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$9.9MMar '26$28.5MJun '26

Net profit, last 8 quarters

$-32.2MSep '24$-31.4MDec '24$-33.5MMar '25$-25.4MJun '25$-30.9MSep '25$86.5MDec '25$56.1MMar '26$13.2MJun '26

Diluted EPS by quarter

-0.56Sep '24-0.54Dec '24-0.58Mar '25-0.43Jun '25-0.47Sep '250.98Dec '250.62Mar '260.15Jun '26

Free cash flow by quarter

$-32.1MSep '24$-29.0MDec '24$-35.9MMar '25$-22.0MJun '25$-18.5MSep '25$-39.8MDec '25$-14.5MMar '26$4.1MJun '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Gross margin97.2%
Operating margin-189.5%
Net margin324.9%
Return on assets51.2%
Current ratio1.95
Liabilities / assets117.9%
Cash & investments$131.95M
Total debt$132.41M
Net cash (debt)-$453,000.00

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Operating Revenue $28.53M $9.89M $0.00 $0.00 $0.00
Cost of Revenue $798,000.00 $587,000.00 – – –
Gross Profit $27.73M $9.31M – – –
Operating Expense $27.66M $26.73M $122.80M $29.08M $26.39M
Selling and Admin Expenses $13.86M $13.37M $41.50M $9.64M $10.40M
Research & Development $13.80M $13.36M $81.30M $19.45M $16.00M
Operating Profit $74,000.00 -$17.42M -$122.80M -$29.08M -$26.39M
Net Non-Operating Interest Income (Expense) -$2.96M -$4.42M $5.06M -$7.61M $13.97M
Non-Operating Interest Income $4.63M $1.48M $5.06M -$7.61M $13.97M
Non-Operating Interest Expense $7.59M $5.89M – – –
Other Income (Expense) $9.55M $73.15M $114.94M $118.59M -$8.82M
Gain on Sale of Security $11.45M $73.15M -$136.72M -$136.04M -$8.82M
Special Income (Charges) -$1.90M – $251.66M $254.63M $0.00
-Less:Other Special Charges $1.90M – -$14.07M -$17.04M –
Pretax Profit $6.67M $51.31M -$2.80M $81.90M -$21.24M
Tax $29,000.00 $57,000.00 $2.01M – –
Net Profit $13.23M $56.06M -$3.35M $86.45M -$30.92M
Profit from Continuing Operations $6.64M $51.25M -$4.81M $79.89M -$21.24M
Net Income from Discontinuous Operations $6.60M $4.81M $1.46M $6.56M -$9.67M
Net Income to Parent Company $13.23M $56.06M -$3.35M $86.45M -$30.92M
Net Income to Common Stockholders $13.23M $56.06M -$3.35M $86.45M -$30.92M
Basic EPS $0.18 $0.78 -$0.05 $1.22 -$0.47
Diluted EPS $0.15 $0.62 -$0.05 $0.98 -$0.47
Total Revenue as Reported – $9.89M – – –
-General & Admin Expense – $13.37M $41.50M $9.64M $10.40M
-Gain on Sale Of Business – – $237.59M – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $286.83M $286.17M $325.63M $325.63M $185.71M
Total Current Assets $185.24M $180.36M $215.67M $215.67M $71.81M
Cash and Cash Equivalents & Short-Term Investments $131.95M $135.32M $171.80M $171.80M $36.09M
-Cash and Cash Equivalents $1.99M $1.91M $9.66M $9.66M $2.40M
-Short Term Investments $129.97M $133.41M $162.14M $162.14M $33.69M
Receivables $46.90M $37.51M $36.27M $36.27M $31.96M
-Accounts Receivable $17.82M $11.85M $6.44M $6.44M $6.05M
-Other Receivables $29.08M $25.66M $29.83M $29.83M $25.92M
Inventory $842,000.00 $183,000.00 – – –
Other Current Assets $5.54M $7.35M $7.60M $7.60M $3.76M
Total Non-Current Assets $101.59M $105.82M $109.97M $109.97M $113.90M
Net PPE $9.66M $11.05M $12.48M $12.48M $13.82M
-Gross PPE $22.13M $23.32M $24.51M $24.51M $25.61M
-Accumulated Depreciation -$12.47M -$12.28M -$12.04M -$12.04M -$11.80M
Non Current Accounts Receivables $90.88M $93.72M $96.44M $96.44M $99.03M
Other Non-Current Assets $1.05M $1.05M $1.05M $1.05M $1.05M
Total Liabilities $338.18M $349.51M $446.86M $446.86M $406.18M
Total Current Liabilities $94.96M $59.44M $78.06M $78.06M $80.76M
Payables $7.00M $6.51M $5.91M $5.91M $12.50M
-Accounts Payable $6.34M $5.37M $4.76M $4.76M $12.50M
-Total Tax Payable $656,000.00 $1.15M $1.15M $1.15M –
Current Accrued Expenses $11.78M $14.10M $15.42M $15.42M $13.61M
Short-Term Debt and Capital Lease Obligation $37.84M $6.41M $23.36M $23.36M $23.21M
-Current Debt $31.26M – $17.06M $17.06M $17.04M
-Current Capital Lease Obligation $6.58M $6.41M $6.30M $6.30M $6.18M
Current Deferred Liabilities $5.00M $2.82M $2.47M $2.47M –
Other Current Liabilities $21.51M $19.86M $20.55M $20.55M $19.30M
Total Non-Current Liabilities $243.22M $290.06M $368.80M $368.80M $325.43M
Non-Current Accrued Expenses $5.70M $5.70M $5.70M $5.70M $4.50M
Long Term Debt and Capital Lease Obligation $101.15M $142.43M $215.78M $215.78M $168.40M
-Long Term Debt $97.25M $136.84M $208.54M $208.54M $159.56M
-Long Term Capital Lease Obligation $3.90M $5.60M $7.25M $7.25M $8.84M
Other Non-Current Liabilities $136.37M $141.93M $147.32M $147.32M $152.53M
Total Equity -$51.35M -$63.33M -$121.23M -$121.23M -$220.48M
Stockholders' Equity -$51.35M -$63.33M -$121.23M -$121.23M -$220.48M
Capital Stock $721,000.00 $720,000.00 $716,000.00 $716,000.00 $700,000.00
-Common Stock $721,000.00 $720,000.00 $716,000.00 $716,000.00 $700,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $792.33M $793.58M $791.75M $791.75M $778.97M
Retained Earnings -$844.40M -$857.64M -$913.70M -$913.70M -$1.00B

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $4.15M -$14.51M -$116.09M -$39.84M -$18.47M
Net cash flow from continuing operations $4.15M -$14.51M -$116.09M -$39.84M -$18.47M
Net Income from Continuing Operations $13.23M $56.06M -$3.35M $86.45M -$30.92M
Depreciation & Depletion & Amortization $193,000.00 $239,000.00 $964,000.00 $235,000.00 $240,000.00
Other Non-Cash Items -$4.64M -$4.70M -$37.13M -$5.56M -$12.61M
Change in Working Capital $3.30M $5.15M $33.72M -$567,000.00 $14.05M
-Change in Receivables -$16.61M $6.23M $30.45M $27.73M $1.25M
-Change in Inventory -$659,000.00 -$183,000.00 – – –
-Change in Prepaid Assets $1.65M $87,000.00 -$1.31M -$2.14M $516,000.00
-Change in Payables and Accrued Expense $2.22M -$979,000.00 $4.58M -$1.75M $3.13M
Net cash flow from investing $3.40M $28.73M $164.52M $111.55M -$6.86M
Net Cash Flow from Continuing Investing Activities $3.40M $28.73M $164.52M $111.55M -$6.86M
Net PPE Purchase and Sale -$45,000.00 $0.00 $239.94M $240.00M -$11,000.00
Net Investment Purchase and Sale $3.45M $28.73M -$75.41M -$128.45M -$6.85M
Financing Cash Flow -$7.47M -$21.98M -$42.17M -$64.44M $25.83M
Net Cash Flow from Continuing Financing Activities -$7.47M -$21.98M -$42.17M -$64.44M $25.83M
Net Issuance Payments Of Debt -$4.60M -$21.93M -$89.16M -$88.59M $6.52M
Net Common Stock Issuance -$5.73M -$4.15M $39.34M $3.72M $29.33M
Proceeds from Stock Option Exercised $2.86M $4.10M $7.65M $7.34M $225,000.00
Ending Cash Balance $1.99M $1.91M $9.66M $9.66M $2.40M
Net Change in Cash $82,000.00 -$7.75M $6.26M $7.27M $491,000.00
Beginning Cash Balance $1.91M $9.66M $3.40M $2.40M $1.90M
Free Cash Flow $4.10M -$14.51M -$116.16M -$39.84M -$18.48M
Gain/Loss from Continuing Operations – – -$255.21M -$258.17M $0.00
-Change in Other Current Assets – – – – $9.15M
Net Other Financing Charges – – – – -$10.26M

Discussion

No comments yet — be the first to weigh in on OMER.

Sign in to join the discussion.

Scroll to Top